12412

541400

ZIMLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZIM LABORATORIES LIMITED Share Price Today

ZIM LABORATORIES LIMITED is currently trading at ₹119.43, up by ₹5.45 from the previous close. The stock touched an intraday high of ₹119.66 and a low of ₹109.00 during the latest trading session. Over the past one year, ZIM LABORATORIES LIMITED has delivered a return of 13.28%, while the stock has gained 18.71% in the last one month.

ZIM LABORATORIES LIMITED performance

Today’s low Today’s high
₹ 109.00 ₹ 119.66
₹ 119.43
52 week low 52 week high
₹ 59.31 ₹ 127.00
₹ 119.43
Open Price ₹ 113.96
Prev. Close ₹ 113.97
Volume (Shares) 309307.00
Total traded value ₹ 369.40
Upper Circuit ₹ 119.66
Lower Circuit ₹ 108.28
info

Investment Returns

Over 1 Month 18.71% Over 3 Months 79.53% Over 6 Months 68.37% Over 1 Year 13.28%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ZIM LABORATORIES LIMITED fundamentals


  • Market cap (Cr) 639.50
  • P/E Ratio (TTM) 107.61
  • Beta 0.87
  • Book Value / share 53.02
  • Return on equity 4.93%
  • EPS (TTM) 0.82
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 3.28
info icon alternate text
  • Market cap (Cr) 639.60
  • P/E Ratio (TTM) 107.61
  • Beta 0.68
  • Book Value / share 53.02
  • Return on equity 4.93%
  • EPS (TTM) 0.82
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 3.28
info icon alternate text

ZIM LABORATORIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 102.85
Operating Expense 104.49
Net Profit 3.28
Net Profit Margin (%) 3.18
Earnings Per Share (EPS) 0.67
EBITDA 12.74
Effective Tax Rate (%) 27.37
Particulars DEC 2025 (Values in Cr)
Revenue 107.81
Operating Expense 103.59
Net Profit 4.26
Net Profit Margin (%) 3.95
Earnings Per Share (EPS) 0.87
EBITDA 14.20
Effective Tax Rate (%) 28.16
Particulars SEP 2025 (Values in Cr)
Revenue 88.39
Operating Expense 90.21
Net Profit 0.12
Net Profit Margin (%) 0.13
Earnings Per Share (EPS) 0.03
EBITDA 8.22
Effective Tax Rate (%) 47.82
Particulars JUN 2025 (Values in Cr)
Revenue 71.43
Operating Expense 75.17
Net Profit -1.69
Net Profit Margin (%) -2.36
Earnings Per Share (EPS) -0.35
EBITDA 5.81
Effective Tax Rate (%) 25.87
Particulars MAR 2025 (Values in Cr)
Revenue 108.52
Operating Expense 101.42
Net Profit 5.42
Net Profit Margin (%) 4.99
Earnings Per Share (EPS) 1.11
EBITDA 16.79
Effective Tax Rate (%) 37.34
Particulars MAR 2026 (Values in Cr)
Revenue 370.48
Operating Expense 373.46
Net Profit 5.97
Net Profit Margin (%) 1.61
Earnings Per Share (EPS) 1.22
EBITDA 40.97
Effective Tax Rate (%) 29.04
Particulars MAR 2025 (Values in Cr)
Revenue 375.64
Operating Expense 363.65
Net Profit 11.74
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 2.41
EBITDA 48.89
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 365.47
Operating Expense 347.12
Net Profit 16.76
Net Profit Margin (%) 4.58
Earnings Per Share (EPS) 3.44
EBITDA 44.79
Effective Tax Rate (%) 27.25
Particulars MAR 2023 (Values in Cr)
Revenue 396.53
Operating Expense 367.05
Net Profit 25.01
Net Profit Margin (%) 6.30
Earnings Per Share (EPS) 5.13
EBITDA 57.62
Effective Tax Rate (%) 30.37
Particulars MAR 2022 (Values in Cr)
Revenue 329.49
Operating Expense 314.71
Net Profit 13.01
Net Profit Margin (%) 3.94
Earnings Per Share (EPS) 8.01
EBITDA 42.45
Effective Tax Rate (%) 32.53
Particulars MAR 2026 (Values in Cr)
Book Value / Share 54.90
ROE % 1.59
ROCE % 4.76
Total Debt to Total Equity 0.45
EBITDA Margin 10.37
Particulars MAR 2025 (Values in Cr)
Book Value / Share 51.49
ROE % 4.96
ROCE % 8.16
Total Debt to Total Equity 0.47
EBITDA Margin 13.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 49.00
ROE % 7.86
ROCE % 9.97
Total Debt to Total Equity 0.40
EBITDA Margin 12.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.12
ROE % 12.99
ROCE % 16.65
Total Debt to Total Equity 0.31
EBITDA Margin 14.65
Particulars MAR 2022 (Values in Cr)
Book Value / Share 108.18
ROE % 8.65
ROCE % 12.43
Total Debt to Total Equity 0.40
EBITDA Margin 13.61
Particulars MAR 2025 (Values in Cr)
Book Value / Share 49.90
ROE % 4.93
ROCE % 8.21
Total Debt to Total Equity 0.48
EBITDA Margin 13.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.60
ROE % 7.87
ROCE % 9.99
Total Debt to Total Equity 0.41
EBITDA Margin 12.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.85
ROE % 13.73
ROCE % 17.30
Total Debt to Total Equity 0.32
EBITDA Margin 14.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.73
ROE % 7.95
ROCE % 11.92
Total Debt to Total Equity 0.41
EBITDA Margin 12.88
Particulars MAR 2021 (Values in Cr)
Book Value / Share 96.69
ROE % 5.84
ROCE % 10.24
Total Debt to Total Equity 0.56
EBITDA Margin 12.93
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 43.41
Total Assets 539.38
Total Liabilities 539.38
Total Equity 296.15
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 1.08
Return on Capital (%) 1.39
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 472.02
Total Liabilities 472.02
Total Equity 252.23
Share Outstanding 4
Price to Book Ratio 1.61
Return on Assets (%) 2.57
Return on Capital (%) 3.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.46
Total Assets 446.82
Total Liabilities 446.82
Total Equity 238.74
Share Outstanding 4
Price to Book Ratio 2.01
Return on Assets (%) 3.85
Return on Capital (%) 5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.51
Total Assets 341.57
Total Liabilities 341.57
Total Equity 200.34
Share Outstanding 4
Price to Book Ratio 1.82
Return on Assets (%) 7.15
Return on Capital (%) 9.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.97
Total Assets 341.62
Total Liabilities 341.62
Total Equity 175.70
Share Outstanding 1
Price to Book Ratio 1.53
Return on Assets (%) 4.25
Return on Capital (%) 6.41
Particulars MAR 2026 (Values in Cr)
Cash & Short Term Investments 36.99
Total Assets 525.19
Total Liabilities 525.19
Total Equity 286.35
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) 1.13
Return on Capital (%) 1.46
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.81
Total Assets 464.38
Total Liabilities 464.38
Total Equity 244.51
Share Outstanding 4
Price to Book Ratio 1.61
Return on Assets (%) 2.52
Return on Capital (%) 3.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.75
Total Assets 442.50
Total Liabilities 442.50
Total Equity 231.95
Share Outstanding 4
Price to Book Ratio 2.01
Return on Assets (%) 3.78
Return on Capital (%) 4.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.20
Total Assets 334.86
Total Liabilities 334.86
Total Equity 194.17
Share Outstanding 4
Price to Book Ratio 1.82
Return on Assets (%) 7.46
Return on Capital (%) 9.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 335.42
Total Liabilities 335.42
Total Equity 170.10
Share Outstanding 1
Price to Book Ratio 1.53
Return on Assets (%) 3.87
Return on Capital (%) 5.88
Particulars MAR 2026 (Values in Cr)
Net Income 8.21
Cash from Operations 53.26
Cash from Investing -56.34
Cash from Financing 28.18
Net change in Cash 23.17
Free Cash Flow 97.65
Particulars MAR 2025 (Values in Cr)
Net Income 18.00
Cash from Operations 40.07
Cash from Investing -39.92
Cash from Financing -9.10
Net change in Cash -7.65
Free Cash Flow 80.87
Particulars MAR 2024 (Values in Cr)
Net Income 23.64
Cash from Operations 18.86
Cash from Investing -73.01
Cash from Financing 59.53
Net change in Cash 3.17
Free Cash Flow 92.78
Particulars MAR 2023 (Values in Cr)
Net Income 35.35
Cash from Operations 45.31
Cash from Investing -36.20
Cash from Financing 0.54
Net change in Cash 3.00
Free Cash Flow 81.98
Particulars MAR 2022 (Values in Cr)
Net Income 21.04
Cash from Operations 49.63
Cash from Investing -14.57
Cash from Financing -32.97
Net change in Cash 2.02
Free Cash Flow 64.86
Particulars MAR 2026 (Values in Cr)
Net Income 8.40
Cash from Operations 51.25
Cash from Investing -57.41
Cash from Financing 28.18
Net change in Cash 18.43
Free Cash Flow 92.88
Particulars MAR 2025 (Values in Cr)
Net Income 17.61
Cash from Operations 49.31
Cash from Investing -41.31
Cash from Financing -9.10
Net change in Cash 0.19
Free Cash Flow 87.23
Particulars MAR 2024 (Values in Cr)
Net Income 23.03
Cash from Operations 14.04
Cash from Investing -71.94
Cash from Financing 59.53
Net change in Cash -0.93
Free Cash Flow 86.63
Particulars MAR 2023 (Values in Cr)
Net Income 35.91
Cash from Operations 42.21
Cash from Investing -35.20
Cash from Financing 0.54
Net change in Cash 0.56
Free Cash Flow 77.88
Particulars MAR 2022 (Values in Cr)
Net Income 19.29
Cash from Operations 47.25
Cash from Investing -14.41
Cash from Financing -32.97
Net change in Cash -0.36
Free Cash Flow 62.22
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA IND LT 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

ZIM LABORATORIES LIMITED shareholding pattern

Holding
69.58%
30.34%
0.07%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ZIM LABORATORIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
119.43 4.79 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 114.20
  • 26 Days 106.20
  • 10 Days 112.10
  • 50 Days 98.40
  • 12 Days 111.30
  • 100 Days 89.40
  • 20 Days 108.40
  • 200 Days 85.50
111.83 PIVOT
First Support 109.64 First Resistance 116.15 Second Support 105.32 Second Resistance 118.34 Third Support 103.13 Third Resistance 122.66
RSI 70.91 ADX 8.26 MACD 5.17 Williams % R -1.17 Commodity Channel Index (CCI) 134.29
Date 2026-05-13 Week 139594.00 Same Day 45194.00 Month 79236.00
1 Year 0.87 3 Year 0.90
Over 1 Month
18.71% down
Over 1 Year
13.28% down
Over 3 Months
79.53% down
Over 3 Years
1.44% down
Over 6 Months
68.37% down
Over 5 Years
0.00% down

ZIM LABORATORIES LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2019 0.5 Final 23 Sep 2019 Equity shares
03 Sep 2018 1.0 Final 04 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
22 Dec 2022 22 Dec 2022 2:1
06 Oct 2018 04 Oct 2018 1:1
Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2019 0.5 Final 23 Sep 2019 Equity shares
03 Sep 2018 1.0 Final 04 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
22 Dec 2022 22 Dec 2022 2:1
06 Oct 2018 04 Oct 2018 1:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zim Laboratories Ltd?

Answer Field

Zim Laboratories Ltd share price is for NSE ₹ 119.43 & for BSE ₹ 116.10 as on Jun 19 2026 03:30 PM.

What is the Market Cap of Zim Laboratories Ltd Share?

Answer Field

The market cap of Zim Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 19 2026 03:30 PM.

What is the 52 Week High and Low of Zim Laboratories Ltd?

Answer Field

The 52 Week High and Low of Zim Laboratories Ltd for NSE is ₹ 127.00 and ₹ 59.31 and for BSE is ₹ 126.95 and ₹ 59.72.

What is 1 year return for Zim Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 13.28%.

What is the P/E Ratio of Zim Laboratories Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM the price-to-earnings (PE) ratio for Zim Laboratories Ltd share is 107.61.

What is the PB ratio of Zim Laboratories Ltd Share?

Answer Field

As on Jun 19 2026 03:30 PM, the price-to-book (PB) ratio for Zim Laboratories Ltd share is 53.02.

How to Buy Zim Laboratories Ltd Share?

Answer Field

You can trade in Zim Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zim Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Zim Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zim Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|